Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis

ObjectiveGH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and obser...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of endocrinology Vol. 168; no. 3; pp. 297 - 305
Main Authors Abs, Roger, Mattsson, Anders F, Thunander, Maria, Verhelst, Johan, Góth, Miklós I, Wilton, Patrick, Kołtowska-Häggström, Maria, Luger, Anton
Format Journal Article
LanguageEnglish
Published Bristol BioScientifica 01.03.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract ObjectiveGH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and observed PP over expected PP ratio (standardized prevalence proportion ratio, SPR) of diabetes according to International Diabetes Federation criteria in a large cohort of GH-untreated adult-onset GHD patients.Design and methodsAssociations between baseline variables and diabetes prevalence in 6050 GHD patients from KIMS (Pfizer International Metabolic Database) were studied and robust Poisson-regression analyses were performed. Comparisons between baseline status and HbA1c categories in the nondiabetic patients were done with covariance analysis. P values <0.05 were considered statistically significant.ResultsPP was 9.3% compared with the expected 8.2%. SPR was 1.13 (95% confidence intervals (95% CIs), 1.04–1.23), which was significantly increased in females (1.23; 95% CI, 1.09–1.38%) but not in males (SPR 1.04; 95% CI, 0.92–1.17%). PP increased significantly by age, familial diabetes, country selection, BMI, waist circumference, number of pituitary deficiencies, and GHD etiology. SPR decreased significantly by age and increased significantly by BMI, waist circumference, and IGF1 SDS. Multiple regression model showed that the most important impact on SPR was from age and BMI. HbA1c values of 6.0–6.5% were found in 9.5% of nondiabetic patients and were associated with higher BMI and waist circumference.ConclusionsGHD is associated with an increased prevalence of diabetes, largely to be explained by the adverse body composition. These data urge toward early initiation of lifestyle modification measures.
AbstractList Objective: GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and observed PP over expected PP ratio (standardized prevalence proportion ratio, SPR) of diabetes according to International Diabetes Federation criteria in a large cohort of GH-untreated adult-onset GHD patients. Design and methods: Associations between baseline variables and diabetes prevalence in 6050 GHD patients from KIMS (Pfizer International Metabolic Database) were studied and robust Poisson-regression analyses were performed. Comparisons between baseline status and HbA1c categories in the nondiabetic patients were done with covariance analysis. P values < 0.05 were considered statistically significant. Results: PP was 9.3% compared with the expected 8.2%. SPR was 1.13 (95% confidence intervals (95% CIs), 1.04-1.23), which was significantly increased in females (1.23; 95% CI, 1.09-1.38%) but not in males (SPR 1.04; 95% CI, 0.92-1.17%). PP increased significantly by age, familial diabetes, country selection, BMI, waist circumference, number of pituitary deficiencies, and GHD etiology. SPR decreased significantly by age and increased significantly by BMI, waist circumference, and IGF1 SDS. Multiple regression model showed that the most important impact on SPR was from age and BMI. HbA1c values of 6.0-6.5% were found in 9.5% of nondiabetic patients and were associated with higher BMI and waist circumference. Conclusions: GHD is associated with an increased prevalence of diabetes, largely to be explained by the adverse body composition. These data urge toward early initiation of lifestyle modification measures. European Journal of Endocrinology 168 297-305
GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and observed PP over expected PP ratio (standardized prevalence proportion ratio, SPR) of diabetes according to International Diabetes Federation criteria in a large cohort of GH-untreated adult-onset GHD patients. Associations between baseline variables and diabetes prevalence in 6050 GHD patients from KIMS (Pfizer International Metabolic Database) were studied and robust Poisson-regression analyses were performed. Comparisons between baseline status and HbA1c categories in the nondiabetic patients were done with covariance analysis. P values <0.05 were considered statistically significant. PP was 9.3% compared with the expected 8.2%. SPR was 1.13 (95% confidence intervals (95% CIs), 1.04-1.23), which was significantly increased in females (1.23; 95% CI, 1.09-1.38%) but not in males (SPR 1.04; 95% CI, 0.92-1.17%). PP increased significantly by age, familial diabetes, country selection, BMI, waist circumference, number of pituitary deficiencies, and GHD etiology. SPR decreased significantly by age and increased significantly by BMI, waist circumference, and IGF1 SDS. Multiple regression model showed that the most important impact on SPR was from age and BMI. HbA1c values of 6.0-6.5% were found in 9.5% of nondiabetic patients and were associated with higher BMI and waist circumference. GHD is associated with an increased prevalence of diabetes, largely to be explained by the adverse body composition. These data urge toward early initiation of lifestyle modification measures.
ObjectiveGH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and observed PP over expected PP ratio (standardized prevalence proportion ratio, SPR) of diabetes according to International Diabetes Federation criteria in a large cohort of GH-untreated adult-onset GHD patients.Design and methodsAssociations between baseline variables and diabetes prevalence in 6050 GHD patients from KIMS (Pfizer International Metabolic Database) were studied and robust Poisson-regression analyses were performed. Comparisons between baseline status and HbA1c categories in the nondiabetic patients were done with covariance analysis. P values <0.05 were considered statistically significant.ResultsPP was 9.3% compared with the expected 8.2%. SPR was 1.13 (95% confidence intervals (95% CIs), 1.04–1.23), which was significantly increased in females (1.23; 95% CI, 1.09–1.38%) but not in males (SPR 1.04; 95% CI, 0.92–1.17%). PP increased significantly by age, familial diabetes, country selection, BMI, waist circumference, number of pituitary deficiencies, and GHD etiology. SPR decreased significantly by age and increased significantly by BMI, waist circumference, and IGF1 SDS. Multiple regression model showed that the most important impact on SPR was from age and BMI. HbA1c values of 6.0–6.5% were found in 9.5% of nondiabetic patients and were associated with higher BMI and waist circumference.ConclusionsGHD is associated with an increased prevalence of diabetes, largely to be explained by the adverse body composition. These data urge toward early initiation of lifestyle modification measures.
Objective GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose to the development of type 2 diabetes mellitus. The aim of this study was to assess the observed prevalence proportion (PP) and observed PP over expected PP ratio (standardized prevalence proportion ratio, SPR) of diabetes according to International Diabetes Federation criteria in a large cohort of GH-untreated adult-onset GHD patients. Design and methods Associations between baseline variables and diabetes prevalence in 6050 GHD patients from KIMS (Pfizer International Metabolic Database) were studied and robust Poisson-regression analyses were performed. Comparisons between baseline status and HbA1c categories in the nondiabetic patients were done with covariance analysis. P values <0.05 were considered statistically significant. Results PP was 9.3% compared with the expected 8.2%. SPR was 1.13 (95% confidence intervals (95% CIs), 1.04–1.23), which was significantly increased in females (1.23; 95% CI, 1.09–1.38%) but not in males (SPR 1.04; 95% CI, 0.92–1.17%). PP increased significantly by age, familial diabetes, country selection, BMI, waist circumference, number of pituitary deficiencies, and GHD etiology. SPR decreased significantly by age and increased significantly by BMI, waist circumference, and IGF1 SDS. Multiple regression model showed that the most important impact on SPR was from age and BMI. HbA1c values of 6.0–6.5% were found in 9.5% of nondiabetic patients and were associated with higher BMI and waist circumference. Conclusions GHD is associated with an increased prevalence of diabetes, largely to be explained by the adverse body composition. These data urge toward early initiation of lifestyle modification measures.
Author Mattsson, Anders F
Góth, Miklós I
Abs, Roger
Verhelst, Johan
Thunander, Maria
Kołtowska-Häggström, Maria
Wilton, Patrick
Luger, Anton
Author_xml – sequence: 1
  givenname: Roger
  surname: Abs
  fullname: Abs, Roger
– sequence: 2
  givenname: Anders F
  surname: Mattsson
  fullname: Mattsson, Anders F
– sequence: 3
  givenname: Maria
  surname: Thunander
  fullname: Thunander, Maria
– sequence: 4
  givenname: Johan
  surname: Verhelst
  fullname: Verhelst, Johan
– sequence: 5
  givenname: Miklós I
  surname: Góth
  fullname: Góth, Miklós I
– sequence: 6
  givenname: Patrick
  surname: Wilton
  fullname: Wilton, Patrick
– sequence: 7
  givenname: Maria
  surname: Kołtowska-Häggström
  fullname: Kołtowska-Häggström, Maria
– sequence: 8
  givenname: Anton
  surname: Luger
  fullname: Luger, Anton
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27158703$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/23211573$$D View this record in MEDLINE/PubMed
https://lup.lub.lu.se/record/3765151$$DView record from Swedish Publication Index
BookMark eNp9kc9rFDEUx4NU7LZ68i65CIKM5udk1puUta2uKKjgLbwkb2hkdmacZCx77x_eDLvWm4dHwjef9328fM_IST_0SMhzzt5wLdnbzcdNxUXFGmYekRVXZl3Vjfx5QlZFUpWqlTwlZyn9YoyXO3tCToUUnGsjV-Tu64R_oMPeIx1aGiI4zJjoDrsu5jnR2NOaaUZv9uMwFiVmmPZ0hByxz4nexnxDIcxdroY-YaaXVzRgG3159nvqsB0mXMQJxw487krXOwr00_XnbxR66PYppqfkcQtdwmfH85z8-LD5fnFVbb9cXl-831ZOa54rpZgQyoCXQrDgmtCKoIwCLmquGKiG-RoCMLEOmtUtMAnMmRqkM1hLUctzsj34plscZ2fHKe7KNnaAaLt5LOVK2YQ2SGUMh8bKoLRV2nsLjqGVmnvkkkNwUOxeHezGafg9Y8p2F5MvHwc9DnOyXDTNeq2VlAV9fUD9NKQ0YfswmzO7pGhLiqXBLikW-sXReHY7DA_s39gK8PIIQPLQtRP0PqZ_nOG6MWzh-IFzcUhLJDmWaOC_w-8ByN62EA
CitedBy_id crossref_primary_10_1159_000499430
crossref_primary_10_3389_fendo_2018_00284
crossref_primary_10_1007_s40618_019_01100_y
crossref_primary_10_3390_cancers15010055
crossref_primary_10_3390_jcm12020662
crossref_primary_10_1016_j_endonu_2015_01_009
crossref_primary_10_1530_EC_18_0096
crossref_primary_10_3389_fendo_2024_1348046
crossref_primary_10_1152_ajpendo_00420_2014
crossref_primary_10_3389_fendo_2020_569633
crossref_primary_10_1111_cen_12603
crossref_primary_10_1007_s11357_022_00680_7
crossref_primary_10_1210_clinem_dgaa089
crossref_primary_10_1111_cen_13256
crossref_primary_10_3389_fendo_2023_1087053
crossref_primary_10_1507_endocrj_EJ15_0337
crossref_primary_10_1007_s11102_016_0747_9
crossref_primary_10_1210_en_2013_1825
crossref_primary_10_1186_s12902_019_0464_2
crossref_primary_10_1007_s12020_016_1076_5
crossref_primary_10_1155_2022_7853786
crossref_primary_10_1007_s11102_021_01173_0
crossref_primary_10_1007_s12020_016_1183_3
crossref_primary_10_3389_fendo_2018_00358
crossref_primary_10_15406_jdmdc_2014_01_00023
crossref_primary_10_1556_650_2023_32890
crossref_primary_10_1038_s41574_021_00539_5
crossref_primary_10_1002_hep4_1953
crossref_primary_10_3389_fendo_2021_626427
crossref_primary_10_4103_ijem_ijem_297_23
crossref_primary_10_1210_jc_2017_01542
crossref_primary_10_1016_j_endoen_2015_05_002
crossref_primary_10_1111_cen_12477
crossref_primary_10_1007_s11102_022_01207_1
crossref_primary_10_1530_EJE_22_0160
crossref_primary_10_1016_j_ghir_2018_12_001
crossref_primary_10_1210_jc_2014_1013
Cites_doi 10.1210/jc.81.2.555
10.1210/jc.2007-0458
10.1111/j.1464-5491.2007.02106.x
10.1016/j.ghir.2005.06.018
10.1210/jc.83.12.4350
10.2337/dc11-0449
10.1210/jc.2011-0448
10.1080/1740028032000131396
10.1530/EJE-09-0291
10.2337/diab.36.4.523
10.1002/pds.1510
10.1016/S0140-6736(02)08655-5
10.1210/er.2008-0027
10.1530/EJE-11-0599
10.1038/ejcn.2009.93
10.1001/archpedi.1975.02120450026006
10.1042/cs0890321
10.1093/epirev/mxm008
10.2337/diacare.24.9.1522
10.1046/j.1365-2265.1999.00695.x
10.1016/0026-0495(95)90004-7
10.1007/s11102-008-0110-x
10.1210/edrv-8-2-115
10.1210/jcem-61-6-1152
10.1159/000071871
10.1093/aje/kwi188
ContentType Journal Article
Copyright 2013 European Society of Endocrinology
2014 INIST-CNRS
Copyright_xml – notice: 2013 European Society of Endocrinology
– notice: 2014 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ADTPV
AOWAS
D95
DOI 10.1530/EJE-12-0807
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
SwePub
SwePub Articles
SWEPUB Lunds universitet
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE

CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
DocumentTitleAlternate Diabetes mellitus in adult-onset GHD
EISSN 1479-683X
EndPage 305
ExternalDocumentID oai_lup_lub_lu_se_d34771a8_3d45_45cc_ab0e_351ce131adba
10_1530_EJE_12_0807
23211573
27158703
Genre Research Support, Non-U.S. Gov't
Multicenter Study
Journal Article
GroupedDBID -
08R
0R
2WC
3O-
4.4
53G
55
5GY
5RE
5VS
AAFZV
AAPBV
ABLYK
ABOCM
ABPTK
ABSGY
ABSQV
ACNCT
ACPRK
ADACO
ADBBV
ADBIT
ADDZX
AENEX
AFFNX
AGCAB
ALMA_UNASSIGNED_HOLDINGS
BAWUL
C1A
CS3
DIK
DU5
E3Z
EBS
EJD
GJ
GX1
H13
HZ
IL9
INIJC
J5H
KQ8
L7B
O0-
O9-
OK1
P2P
RHF
SJN
TBS
TR2
VH1
WOQ
X
X7M
ZA5
ZGI
ZXP
---
-~X
.55
.GJ
0R~
18M
ACGFO
ADGIM
AFHIN
AI.
BTFSW
F9R
HZ~
IQODW
W8F
5WD
AABZA
AACZT
AAPGJ
AAPXW
AARHZ
AAUAY
AAVAP
AAWDT
ABMNT
ABNHQ
ABPQP
ABPTD
ABQNK
ABWST
ABXVV
ACFRR
ACUTJ
ADIPN
ADQBN
ADVEK
AFGWE
AFYAG
AGQXC
AGUTN
AJEEA
ANFBD
APJGH
ATGXG
BCRHZ
CGR
CUY
CVF
ECM
EIF
EMOBN
KOP
NPM
OAUYM
OBOKY
OCZFY
OJZSN
OPAEJ
OVD
OWPYF
ROX
TCN
TEORI
TMA
AAYXX
CITATION
7X8
ADTPV
AOWAS
D95
ID FETCH-LOGICAL-b551t-4402247ac3220db8df2d474a126140a480c6ada029d506fa03a0b76a3b7e63263
ISSN 0804-4643
1479-683X
IngestDate Sat Aug 24 00:45:18 EDT 2024
Fri Aug 16 23:57:11 EDT 2024
Fri Aug 23 02:57:40 EDT 2024
Sat Sep 28 07:57:01 EDT 2024
Fri Nov 25 06:02:12 EST 2022
Wed Apr 14 02:20:59 EDT 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Endocrinopathy
Human
Replacement therapy
Prevalence
Diabetes mellitus
Deficiency
Patient
Epidemiology
Somatotropin
Adenohypophyseal hormone
Hypophyseal insufficiency
Pituitary diseases
Adult
Endocrinology
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-b551t-4402247ac3220db8df2d474a126140a480c6ada029d506fa03a0b76a3b7e63263
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1530/EJE-12-0807
PMID 23211573
PQID 1288995433
PQPubID 23479
PageCount 9
ParticipantIDs swepub_primary_oai_lup_lub_lu_se_d34771a8_3d45_45cc_ab0e_351ce131adba
proquest_miscellaneous_1288995433
crossref_primary_10_1530_EJE_12_0807
pubmed_primary_23211573
pascalfrancis_primary_27158703
bioscientifica_primary_10_1530_EJE_12_0807
PublicationCentury 2000
PublicationDate 2013-03-01
PublicationDateYYYYMMDD 2013-03-01
PublicationDate_xml – month: 03
  year: 2013
  text: 2013-03-01
  day: 01
PublicationDecade 2010
PublicationPlace Bristol
PublicationPlace_xml – name: Bristol
– name: England
PublicationTitle European journal of endocrinology
PublicationTitleAlternate Eur J Endocrinol
PublicationYear 2013
Publisher BioScientifica
Publisher_xml – name: BioScientifica
References Gutierrez (13_30137256) 2008; 17
Qiao (26_35528359) 2010; 64
Hillier (24_11295352) 2001; 24
(8_45189668) 1995; 89
Brabant (17_17733160) 2003; 60
(20_39828145) 2011; 96
(7_35411243) 2009; 161
Johansson (9_16000472) 1995; 44
(3_28235338) 1989; 256
(28_35824394) 2005; 15
(14_35824399) 2003; 1
Harris (22_14064530) 1987; 36
(1_39932134) 2009; 30
BOUGNERES (6_13645348) 1985; 61
(19_19264965) 2005; 162
(21_29015811) 2007; 92
Cordido (11_6261237) 1998; 83
Bennett (29_27989582) 2007; 24
(30_41190729) 2012; 35
Hopwood (5_20126848) 1975; 129
(15_36172415) 2008; 11
(25_28549156) 2007; 29
(23_40892942) 2011; 165
DAVIDSON (2_14204025) 1987; 8
(4_45189667) 1991; 260
Hew (10_16231559) 1996; 81
Sandhu (27_17087722) 2002; 359
Abs (12_10946879) 1999; 50
References_xml – volume: 81
  start-page: 555
  issn: 0021-972X
  issue: 2
  year: 1996
  ident: 10_16231559
  publication-title: Journal of Clinical Endocrinology & Metabolism
  doi: 10.1210/jc.81.2.555
  contributor:
    fullname: Hew
– volume: 92
  start-page: 3560
  issn: 0021-972X
  issue: 9
  year: 2007
  ident: 21_29015811
  publication-title: Journal of Clinical Endocrinology & Metabolism
  doi: 10.1210/jc.2007-0458
– volume: 24
  start-page: 333
  issn: 0742-3071
  issue: 4
  year: 2007
  ident: 29_27989582
  publication-title: Diabetic medicine : a journal of the British Diabetic Association
  doi: 10.1111/j.1464-5491.2007.02106.x
  contributor:
    fullname: Bennett
– volume: 15
  start-page: 349
  year: 2005
  ident: 28_35824394
  publication-title: GROWTH HORMONE IGF RESEARCH
  doi: 10.1016/j.ghir.2005.06.018
– volume: 83
  start-page: 4350
  issn: 0021-972X
  issue: 12
  year: 1998
  ident: 11_6261237
  publication-title: Journal of Clinical Endocrinology & Metabolism
  doi: 10.1210/jc.83.12.4350
  contributor:
    fullname: Cordido
– volume: 35
  start-page: 57
  issn: 0149-5992
  issue: 1
  year: 2012
  ident: 30_41190729
  publication-title: Diabetes Care
  doi: 10.2337/dc11-0449
– volume: 96
  start-page: 2255
  issn: 0021-972X
  issue: 7
  year: 2011
  ident: 20_39828145
  publication-title: Journal of Clinical Endocrinology & Metabolism
  doi: 10.1210/jc.2011-0448
– volume: 256
  start-page: E835
  issn: 0002-9513
  year: 1989
  ident: 3_28235338
  publication-title: American Journal of Physiology -- Legacy Content
– volume: 1
  start-page: 15
  year: 2003
  ident: 14_35824399
  publication-title: NEW REVIEW OF BIOETHICS
  doi: 10.1080/1740028032000131396
– volume: 161
  start-page: S41
  issn: 0804-4643
  issue: suppl_1
  year: 2009
  ident: 7_35411243
  publication-title: European Journal of Endocrinology
  doi: 10.1530/EJE-09-0291
– volume: 36
  start-page: 523
  issn: 0012-1797
  issue: 4
  year: 1987
  ident: 22_14064530
  publication-title: Diabetes
  doi: 10.2337/diab.36.4.523
  contributor:
    fullname: Harris
– volume: 17
  start-page: 90
  issn: 1053-8569
  issue: 1
  year: 2008
  ident: 13_30137256
  publication-title: Pharmacoepidemiology and drug safety
  doi: 10.1002/pds.1510
  contributor:
    fullname: Gutierrez
– volume: 359
  start-page: 1740
  issn: 0140-6736
  issue: 9319
  year: 2002
  ident: 27_17087722
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)08655-5
  contributor:
    fullname: Sandhu
– volume: 30
  start-page: 152
  issn: 0163-769X
  issue: 2
  year: 2009
  ident: 1_39932134
  publication-title: Endocrine Reviews
  doi: 10.1210/er.2008-0027
– volume: 165
  start-page: 881
  issn: 0804-4643
  issue: 6
  year: 2011
  ident: 23_40892942
  publication-title: European Journal of Endocrinology
  doi: 10.1530/EJE-11-0599
– volume: 64
  start-page: 30
  issn: 1476-5640
  issue: 1
  year: 2010
  ident: 26_35528359
  publication-title: European Journal of Clinical Nutrition
  doi: 10.1038/ejcn.2009.93
  contributor:
    fullname: Qiao
– volume: 129
  start-page: 918
  issn: 0096-8994
  issue: 8
  year: 1975
  ident: 5_20126848
  publication-title: Archives of Pediatrics and Adolescent Medicine
  doi: 10.1001/archpedi.1975.02120450026006
  contributor:
    fullname: Hopwood
– volume: 89
  start-page: 321
  issn: 0009-9287
  year: 1995
  ident: 8_45189668
  publication-title: Clinical science
  doi: 10.1042/cs0890321
– volume: 29
  start-page: 115
  issn: 0193-936X
  issue: 1
  year: 2007
  ident: 25_28549156
  publication-title: Epidemiologic Reviews
  doi: 10.1093/epirev/mxm008
– volume: 24
  start-page: 1522
  issn: 0149-5992
  issue: 9
  year: 2001
  ident: 24_11295352
  publication-title: Diabetes Care
  doi: 10.2337/diacare.24.9.1522
  contributor:
    fullname: Hillier
– volume: 260
  start-page: E395
  issn: 0002-9513
  year: 1991
  ident: 4_45189667
  publication-title: American Journal of Physiology -- Legacy Content
– volume: 50
  start-page: 703
  issn: 0300-0664
  issue: 6
  year: 1999
  ident: 12_10946879
  publication-title: Clinical endocrinology
  doi: 10.1046/j.1365-2265.1999.00695.x
  contributor:
    fullname: Abs
– volume: 44
  start-page: 1126
  issn: 0026-0495
  issue: 9
  year: 1995
  ident: 9_16000472
  publication-title: Metabolism: clinical and experimental
  doi: 10.1016/0026-0495(95)90004-7
  contributor:
    fullname: Johansson
– volume: 11
  start-page: 121
  issn: 1573-7403
  year: 2008
  ident: 15_36172415
  doi: 10.1007/s11102-008-0110-x
– volume: 8
  start-page: 115
  issn: 0163-769X
  issue: 2
  year: 1987
  ident: 2_14204025
  publication-title: Endocrine Reviews
  doi: 10.1210/edrv-8-2-115
  contributor:
    fullname: DAVIDSON
– volume: 61
  start-page: 1152
  issn: 0021-972X
  issue: 6
  year: 1985
  ident: 6_13645348
  publication-title: Journal of Clinical Endocrinology & Metabolism
  doi: 10.1210/jcem-61-6-1152
  contributor:
    fullname: BOUGNERES
– volume: 60
  start-page: 53
  issn: 0301-0163
  issue: 2
  year: 2003
  ident: 17_17733160
  publication-title: Hormone research
  doi: 10.1159/000071871
  contributor:
    fullname: Brabant
– volume: 162
  start-page: 199
  issn: 0002-9262
  issue: 3
  year: 2005
  ident: 19_19264965
  publication-title: American Journal of Epidemiology
  doi: 10.1093/aje/kwi188
SSID ssj0016430
Score 2.2976608
Snippet ObjectiveGH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus...
GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus predispose...
Objective GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus...
OBJECTIVEGH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus...
Objective: GH deficiency (GHD) in adults is characterized by a tendency toward obesity and an adverse body composition with visceral fat deposit and may thus...
SourceID swepub
proquest
crossref
pubmed
pascalfrancis
bioscientifica
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 297
SubjectTerms Adult
Age of Onset
Aged
Biological and medical sciences
Body Mass Index
Clinical Medicine
Clinical Study
Cohort Studies
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - etiology
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinology and Diabetes
Endocrinopathies
Endokrinologi och diabetes
Epidemiology
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Europe - epidemiology
Female
Fundamental and applied biological sciences. Psychology
General aspects
Glycated Hemoglobin A - analysis
Human Growth Hormone - deficiency
Humans
Hypopituitarism - blood
Hypopituitarism - complications
Hypopituitarism - physiopathology
Klinisk medicin
Male
Medical and Health Sciences
Medical sciences
Medicin och hälsovetenskap
Middle Aged
Overweight - complications
Poisson Distribution
Prevalence
Public health. Hygiene
Public health. Hygiene-occupational medicine
Sex Factors
United States - epidemiology
Vertebrates: endocrinology
Young Adult
Title Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
URI http://dx.doi.org/10.1530/EJE-12-0807
https://www.ncbi.nlm.nih.gov/pubmed/23211573
https://search.proquest.com/docview/1288995433
https://lup.lub.lu.se/record/3765151
Volume 168
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAIEGwDymUy0sQDVUYSO5fyVqHSMjSeOrS3yI4dWokmUZs-jGf-Av-XcxwnaWFDwEOjynESqd8Xn0u_c0zIsR8qXwuIVLniWJKjhCPTlDng6UqZxdgiDAuFzz6F03N-ehFc9Ho_tlRLm0qepN-urCv5H1RhDHDFKtl_QLa9KQzAd8AXjoAwHP8KY-y_JEzVEPp8bRp1iU02q41RukIc4Q7ml2VRwsiiQo2cbaXa1LVhAw4HNdXVYDIdKI0tJUw9ptTg0GocXGkj3WoSiWLw8QPE_8L2M7k2uW8dXZ2rAtam3QT-SNYpnuJLJw_GvcfXtgJsZIpuOt3xbL4x-e6VLTBatObks17NwcBXVlhs2W4TGbipRKPkOtH14sujoRPGZn_gbnUO4y0asu21thb2_mYDAoaiyfHp2KhOYndnFvxK5dLQAVxJbDTEOkPYyhObUzfITT8aBqgUnVy0yiEIMJlrSz3hWW-2noStpe21d8g9uaj7kRrR167jc7cUa3gHs3rzlKuim19a1xp3Z_aA3LdxCh3VpHtIejrfJwejXFTF8pK-okY5bBDdJ7fOrEDjgHzvKEmLjDaUpA0l6SKnSEm6Q0naUJIiJekWJelkSjtK0pqSOLhFybdUUCQkbQh5SM7fj2fvpo7d6MOR4LBXDufoSUYiBeviKhmrzFc84sKD8J67gsduGgolXH-oAjfMhMuEK6NQMBnpEOIP9ojs5UWunxAaazYEu5TGQmQ89LQc8kyozFNRxDztqj55vQtLUtZdXRKMhgHOBOBMPD9BOPvkuIHsz9OOduBs5_qRF4A9ZH3yssE3gdUb_5ITuS42a7hDHGNHRgZzHtfAd1dbJvXJuGZCewZbwn_dlPCR8EnWOlGMR5En4oQpHiQ8SNNESFcnLPBS7TFPKCmeXvuEZ-R290I-J3vVaqNfgK9dySPD_J9cd9aR
link.rule.ids 230,315,786,790,891,27955,27956
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+diabetes+mellitus+in+6050+hypopituitary+patients+with+adult-onset+GH+deficiency+before+GH+replacement%3A+a+KIMS+analysis&rft.jtitle=European+journal+of+endocrinology&rft.au=Abs%2C+Roger&rft.au=Mattsson%2C+Anders+F&rft.au=Thunander%2C+Maria&rft.au=Verhelst%2C+Johan&rft.date=2013-03-01&rft.eissn=1479-683X&rft.volume=168&rft.issue=3&rft.spage=297&rft_id=info:doi/10.1530%2FEJE-12-0807&rft_id=info%3Apmid%2F23211573&rft.externalDocID=23211573
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0804-4643&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0804-4643&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0804-4643&client=summon